Choleresis and inhibition of biliary lipid secretion induced by piperacillin in the rat

1. The effects of the administration piperacillin on bile flow and biliary lipid secretion were studied in male Wistar rats.

[1]  A. Groen,et al.  The mechanism of biliary lipid secretion and its defects. , 1999, Gastroenterology clinics of North America.

[2]  C. Green,et al.  The Formation of Desethyl‐Piperacillin from Piperacillin by Human Liver S9 in vitro , 1997, Biopharmaceutics & drug disposition.

[3]  D. Cohen,et al.  Hepatocellular Transport and Secretion of Biliary Phospholipids , 1996, Seminars in liver disease.

[4]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[5]  J. Boyer,et al.  Papaverine inhibits transcytotic vesicle transport and lipid excretion into bile in isolated perfused rat liver , 1992, Hepatology.

[6]  J. González‐Gallego,et al.  Alterations induced by fascioliasis and cirrhosis on the biliary excretion of cefmetazole in Wistar rats. , 1992, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[7]  H. Monteil,et al.  Evaluation de l'élimination biliaire de la pipéracilline chez l'homme: possibilité d'une métabolisation hépatique , 1991 .

[8]  J. Boyer,et al.  Mechanisms and regulation of bile secretion , 1991, Hepatology.

[9]  F. Cava,et al.  Inhibition of biliary cholesterol and phospholipid secretion by cefmetazole. The role of vesicular transport and of canalicular events. , 1991, The Biochemical journal.

[10]  J. Arnaud,et al.  Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man. , 1990, International journal of clinical pharmacology, therapy, and toxicology.

[11]  J. Blicklé,et al.  [Biliary elimination and hepatic disposition of piperacillin: experimental evaluation]. , 1990, Pathologie-biologie.

[12]  I. Tamai,et al.  Membrane potential-dependent and carrier-mediated transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver plasma membrane vesicles. , 1990, The Journal of pharmacology and experimental therapeutics.

[13]  E. Mariño,et al.  Biliary excretion and choleretic effect of cefmetazole in rats , 1989, Antimicrobial Agents and Chemotherapy.

[14]  M. Monte,et al.  Inhibition of biliary cholesterol and phospholipid secretion during cyclobutyrol-induced hydrocholeresis. , 1989, The Biochemical journal.

[15]  R. Coleman,et al.  Ampicillin inhibits the movement of biliary secretory vesicles in rat hepatocytes. , 1988, Biochimica et biophysica acta.

[16]  K. Tsukada,et al.  Effect of ursodeoxycholate on the biliary excretion of cefotiam and sulbenicillin in patients with percutaneous transhepatic biliary drainage , 1988, Antimicrobial Agents and Chemotherapy.

[17]  A. Gerding,et al.  Biliary lipid secretion in the rat. The uncoupling of biliary cholesterol and phospholipid secretion from bile acid secretion by sulfated glycolithocholic acid. , 1987, Biochimica et biophysica acta.

[18]  C. Roy,et al.  Effect of complete sulfation of bile acids on bile formation in rats , 1987, Hepatology.

[19]  J. Hanks,et al.  Experimental Studies of Biliary Excretion of Piperacillin , 1987, Annals of surgery.

[20]  L. Clavell,et al.  Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia. , 1987, Puerto Rico health sciences journal.

[21]  A. Hofmann,et al.  Influence of bile acid structure on bile flow and biliary lipid secretion in the hamster. , 1984, The American journal of physiology.

[22]  E. W. Taylor,et al.  Biliary Excretion of Piperacillin , 1983, The Journal of international medical research.

[23]  R. Finley,et al.  Piperacillin Sodium: Antibacterial Spectrum, Pharmacokinetics, Clinical Efficacy, and Adverse Reactions , 1982, Pharmacotherapy.

[24]  B. Saxon,et al.  Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients , 1982, Antimicrobial Agents and Chemotherapy.

[25]  C. Klaassen,et al.  Choleretic effect of valproic acid in the rat , 1981, Hepatology.

[26]  B. Meyers,et al.  Biliary concentrations of piperacillin in patients undergoing cholecystectomy , 1981, Antimicrobial Agents and Chemotherapy.

[27]  B. Combes,et al.  Choleresis associated with metabolism and biliary excretion of diethyl maleate in the rat and dog. , 1978, The Journal of pharmacology and experimental therapeutics.

[28]  D. Small,et al.  The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man. , 1978, The Journal of clinical investigation.

[29]  L. Verbist.  In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity , 1978, Antimicrobial Agents and Chemotherapy.

[30]  A. Hofmann,et al.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates. , 1973, Gastroenterology.

[31]  H. O. Wheeler,et al.  Biliary excretion of lecithin and cholesterol in the dog. , 1972, The Journal of clinical investigation.

[32]  M. Dupon,et al.  Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients , 2004, European Journal of Clinical Pharmacology.

[33]  J. Blicklé,et al.  Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation. , 1994, Drugs under experimental and clinical research.

[34]  M. Apstein.  Inhibition of biliary phospholipid and cholesterol secretion by bilirubin in the Sprague-Dawley and Gunn rat. , 1984, Gastroenterology.

[35]  K. Mashimo.  Penetration of antibiotics into bile. , 1978, Scandinavian journal of infectious diseases. Supplementum.

[36]  P. Talalay.  Enzymic analysis of steroid hormones. , 1960, Methods of biochemical analysis.